Sort   by:  
 Page size 
UnknownPredicting response to cancer immunotherapy using noninvasive radiomic biomarkers.
Not available
S-EPMC6594459 | biostudies-literature
UnknownAdjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
Not available
S-EPMC5538020 | biostudies-literature
UnknownThe advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.
Not available
S-EPMC4802157 | biostudies-literature
UnknownAssessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Not available
S-EPMC3235950 | biostudies-literature
UnknownLetrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
Not available
S-EPMC2921823 | biostudies-literature
Sort   by:  
 Page size